May 21, 2024
https://blogs.oncolink.org/2021/02/rare-disease-day-raising-awareness-for-rare-cancers/

Yearly on the final day of February, the world acknowledges uncommon ailments—a day now referred to as Rare Disease Day. Uncommon ailments have an effect on roughly 25 million to 30 million folks in the USA annually. The aim of Uncommon Illness Day is to teach the general public and lift consciousness amongst decision-makers in regards to the affect of uncommon ailments on sufferers’ lives. Determination-makers embrace those that make strides advancing crucial analysis: policymakers, trade representatives, well being professionals, advocates, and extra. By means of their help, extra motion could be taken to fight uncommon ailments.

Based on the National Cancer Institute (NCI), about one-quarter of all most cancers deaths annually are attributable to uncommon cancers. And, in reality, most varieties of most cancers are thought-about uncommon. Sadly, uncommon cancers are more difficult to deal with than widespread cancers—and they’re tougher to analysis due to the restricted variety of sufferers. Different points associated to uncommon cancers embrace lack of understanding amongst physicians about uncommon cancers, and issue discovering consultants who can reply questions.

Regardless of these obstacles, researchers do discover methods to check uncommon cancers and develop higher prevention methods and coverings. For instance, in June 2020 the results of the primary randomized medical trial for inoperable anal most cancers decided one of the best chemotherapy routine for sufferers. Earlier than the trial, the standard method for these sufferers was palliative care or care that focuses on offering reduction from ache and different signs. Now, researchers are constructing on their findings in a phase III clinical trial that may add an immunotherapy drug to chemotherapy to hopefully enhance affected person care even additional.

A medical trial could also be a good selection for somebody identified with a uncommon most cancers, although sufferers ought to all the time talk about remedy choices with their physician first. Details about most cancers medical trials is accessible in OncoLink’s Clinical Trials section, which additionally features a useful clinical trial matching service. Examples of uncommon most cancers medical trials which might be presently accessible embrace:

  • Neuroendocrine tumors (NETs)
  • Penile most cancers
  • Mantle cell lymphoma

In the USA, NETs happen in about 12,000 folks annually; these tumors can seem in any a part of the physique, however usually develop within the lungs, gastrointestinal tract, or pancreas. Mantle cell lymphoma, a uncommon kind of non-Hodgkin lymphoma, impacts about 4,200 folks yearly whereas penile most cancers impacts simply 2,200 folks annually. As a way to be thought-about “uncommon,” a most cancers can solely happen in 40,000 folks or fewer per yr within the US. Nevertheless, when taken collectively, uncommon cancers are literally extra widespread than breast, colon, lung, or prostate most cancers. And, folks going through uncommon cancers are simply as in want of higher prevention, therapies, and cures as these going through widespread cancers.

For uncommon most cancers assets or help, go to NORD, the National Cancer Institute or Cancer.Net. Contemplate becoming a member of the motion on February 28 by sharing your expertise with uncommon ailments on social media utilizing the hashtag #RareDiseaseDay. As consciousness of uncommon ailments—like uncommon most cancers—will increase, so do enhancements in affected person care and outcomes.


Katie Heller, MA, is a visitor author who works in advertising and marketing and medical training at ECOG-ACRIN Most cancers Analysis Group. Beforehand, she held roles on the American Society of Medical Oncology and their basis, Conquer Most cancers. She has practically a decade of expertise in oncology and well being care communications. Katie obtained a Bachelor’s Diploma in English from Loyola College Maryland and a Grasp’s Diploma in Media, Tradition, and Communication from New York College.